文献速递内脏/肾动脉与血管畸形

肾动脉瘤腔内与外科治疗的临床结局

Clinical Outcomes of Endovascular and Surgical Treatments for Renal Artery Aneurysm.
PubMed 文献 · Ann Vasc Surg · 2026-06-11

单中心回顾性研究分析52例肾动脉瘤手术,比较腔内与外科治疗的临床结局。两组技术成功率均100%,腔内组肾梗死发生率更高(67.9% vs 37.5%,P=0.03),但长期肾功能结局无显著差异。治疗选择应基于动脉瘤解剖和患者个体化因素。

要点

  • 腔内与外科治疗肾动脉瘤技术成功率均高,肾功能保留良好
  • 腔内组肾梗死更常见,但多为微小梗死
  • 两组AKI、肾动脉闭塞、CKD≥3期及GFR变化无显著差异

核心结论

  • 腔内与外科治疗RAA均具有高技术成功率和肾功能保留。
  • 腔内治疗与更高的肾梗死发生率及潜在迟发血管并发症相关,但长期肾功能结局相当。

研究设计与样本

  • 比较腔内组(28例)与外科组(24例)的基线特征、动脉瘤解剖及临床结局。

主要发现

  • 平均RAA大小为2.5 cm(范围0.8-6.5 cm)。
  • 腔内组28例:17例弹簧圈栓塞、8例支架辅助弹簧圈栓塞、3例覆膜支架置入。
  • 外科组24例:15例原位修复、9例自体移植。
  • 两组技术成功率均为100%。
  • 肾梗死发生率腔内组更高(67.9% vs 37.5%;P=0.03),主要由微小梗死驱动。

临床怎么用

  • 治疗选择应基于动脉瘤解剖和患者个体化因素。
  • 腔内治疗需关注肾梗死风险,尤其是微小梗死。

局限性

  • 单中心回顾性设计,样本量较小(52例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A renal artery aneurysm (RAA) is usually asymptomatic and requires no treatment. RAAs larger than 2-3 cm however are at risk of rupture and typically require intervention. This study analyzed the clinical outcomes of endovascular and surgical treatments for RAA. METHODS: This single-center retrospective observational study reviewed 52 RAA procedures performed between January 2011 and December 2024. Baseline patient characteristics, aneurysm anatomy, and clinical outcomes-including technical success, postprocedural renal infarction, perioperative outcomes, and long-term renal outcomes-were compared between endovascular and surgical groups. RESULTS: The mean RAA size was 2.5 cm (range, 0.8-6.5 cm). Endovascular treatment was performed in 28 procedures (17 coil embolizations, 8 stent-assisted coil embolizations, and 3 stent graft insertions), and surgical treatment in 24 procedures (15 in situ repairs, 9 autotransplantations). Technical success was 100% in both groups. Renal infarction occurred more frequently in the endovascular group (67.9% vs. 37.5%; P = 0.03), driven primarily by minimal infarction. The incidence of acute kidney injury (AKI) (10.7% vs. 29.2%; P = 0.16), renal artery occlusion (7.1% vs. 0%; P = 0.49), chronic kidney disease (CKD) stage ≥ 3 (14.3% vs. 4.2%; P = 0.36), and mean glomerular filtration rate (GFR) change (-15.71 vs. -13.92; P = 0.59) did not differ significantly between groups. CONCLUSION: Both endovascular and surgical treatments for RAA demonstrate high technical success and preservation of renal function. Endovascular treatment is associated with a higher incidence of renal infarction and potentially delayed vascular complications; however, long-term renal outcomes were comparable. Treatment selection should be individualized based on aneurysm anatomy and patient-specific considerations.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lee SA, Yi B, Gwon JG, et al. Clinical Outcomes of Endovascular and Surgical Treatments for Renal Artery Aneurysm. Ann Vasc Surg. 2026. PMID: 42276361. doi:10.1016/j.avsg.2026.05.102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。